The heterotopically induced ossicles are used in our research on bone tissue. The ossicles are formed in the thigh muscle of BALB/c mice under the influence of injected suspension of 3 × 106 HeLa cells. We postulate that the mechanism of bone induction is based on the secretion of bone morphogenetic proteins BMP-4 and BMP-6 by the grafted HeLa cells. This was proved by the use of specific immunohistochemical reaction and Western blots of conditioned culture medium. It seems that HeLa cells secrete BMPs continuously into the culture medium, even without contact with the mice muscle tissue, were induction of bone tissue is observed.
HugginsCB. The formation of bone under the influence of epithelium of the urinary tract. Arch Surg22: 377–408, 1931.
2.
UristMR. Bone formation by autoinduction. Science150: 893–899, 1965.
3.
AndersonHC, MarkerPC, FoghJ. Formation of tumors containing bone after intramuscular injection of transformed human amnion cells (FL) into cortisone-treated mice. Am J Pathol54: 507–513, 1964.
4.
WlodarskiK, KobusM, LuczakM. Orthotopic bone induction at sites of Moloney murine sarcoma virus inoculation in mice. Nature281: 386–387, 1979.
5.
WangEA, RosenV, CordesP, HewickRM, KrizMJ, LuxenbergDP, SibleyBS, WozneyJM. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci U S A85: 9484–9488, 1988.
6.
SampathTK, MuthukumaranN, ReddiAM. Isolation of osteogenin, an extracellular matrix-associated bone-inductive protein, by heparin affinity chromatography. Proc Natl Acad Sci U S A84: 7109–7113, 1987.
7.
WozneyJM, RosenV, CelesteAJ, MitspckLM, WhittersMJ, KrizRV, HewickRM, WangEA. Novel regulators of bone formation: molecular clones and activities. Science242: 1528–1534, 1988.
8.
HoganBL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Gene Dev10: 1580–1594, 1996.
9.
WozneyJM. Bone morphogenetic proteins. Prog Growth Factor Res1: 267–280, 1989.
10.
YamashitaH, Ten DijkeP, HeldinCH, MiyazonoK. Bone morphogenetic protein receptors. Bone19: 569–574, 1996.
11.
SampathTK, CoughlinJE, WhetstoneRM, BanachD, CorbettC, RidgeRJ, OzkaynakE, OppermannK, RuegerD. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. J Biol Chem265: 13198–13205, 1990.
12.
DuboisCM, LapriseMH, BlanchetteF, GentryLE, LeducR. Processing of transforming growth factor-β1 precursor by human furin convertase. J Biol Chem270: 10618–10624, 1995.
13.
LyonsK, GraycarJL, LeeA, HashmiS, LindquistPB, ChenEY, HoganBL, DerynckR. Vgr-1, a mammalian gene related to Xenopus Vg-1, is a member of the transforming growth factor-β gene superfamily. Proc Natl Acad Sci U S A86: 4554–4558, 1989.
14.
OzkaynakE, SchnegelsbergPN, OppermannH. Murine osteogenic protein (OP-1): high levels of mRNA in kidney. Biochem Biophys Res Commun179: 116–123, 1991.
15.
RaidaM, SarbiaM, ClementJH, AdamS, GabbertHE, HofikenK. Expression, regulation and clinical significance of bone morphogenetic protein 6 in esophageal squamous cell carcinoma. Int J Cancer83(1):38–44, 1999.
16.
MarshallCJ, KinnonC, TrasherAJ. Polarized expression of bone morphogenetic protein-4 in the human aorta-gonad-mesonephrus region. Blood96(4):1591–1593, 2000.
17.
BentleyH, HamdyFC, HartKA. Expression of bone morphogenetic protein in human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer66: 1159–1163, 1992.
18.
WallNA, BlessingM, WrightCVE. Biosynthesis and in vivo localization of the decapentaplegic-Vg-related protein DVR-6 (bone morphogenetic protein-6). J Cell Biol120(2):493–502, 1993.
19.
DrozdoffV, WallNA, PledgerWJ. Expression and growth inhibitory effect of decapentaplegic Vg-related protein 6: evidence for a regulatory role in keratynocyte differentiation. Proc Natl Acad Sci U S A91: 5528–5532, 1994.
20.
MasuharaK, NakaseT, SuzukiS, TakaokaK, MatsuiM., AndersonHC. Use of monoclonal antibody to detect bone morphogenetic protein-4 (MBP-4). Bone16: 91–96, 1995.
21.
CelesteAJ, IannazziJA, TaylorRC, HewickRM, RosenV, WangEA, WozneyJM. Identification of transforming growth factor-β family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A87: 9843–9847, 1990.
22.
FengJQ, ChenD, CooneyAJ, TsaiMJ, HarrisMA, TsaiSY, FengM, MundyGR, HarrisSE. The mouse bone morphogenetic protein-4 gene: analysis of promoter utilization in fetal rat calvarial osteoblasts and regulation by COUP-TFI orphan receptor. J Biol Chem270: 28364–28373, 1995.
23.
GoltzmanD, KaraplisAC, KremerR, RabbaniSA. Molecular basis of the spectrum of skeletal complications of neoplasia. Cancer88: 2903–2908, 2000.
24.
AndersonHC, SugamotoK, MorrisDC, HsuHH, HuntT. Bone-inducing agent (BIA) from cultured human Saos-2 osteosarcoma cells. Bone Miner16: 49–62, 1992.
25.
RavalP, HsuHH, SchneiderDJ, SarrasMPJr., MasuharaK, BonewaldLF, AndersonHC. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells. J Dent Res75: 1518–1523, 1996.
26.
IzbickaE, DunstanCR, EsparzaJ, JacobsC, SabatiniM, MundyGR. Human amniotic tumor that induces new bone formation in vivo produces a growth-regulatory activity in vitro for osteoblasts identified as an extended form of basic fibroblast growth factor. Cancer Res56: 633–636, 1996.
27.
IzbickaE, DunstanCR, HornP, HarrisM, HarrisS, AdamsR, MundyGR. Effects of human tumor cell lines on local new bone formation in vivo. Calcif Tiss Int60: 210–215, 1997.
28.
TokunagaK, OgoseA, EndoN, NomuraS, TakahishiHE. Human osteosarcoma (OST) induces mouse reactive bone formation in xenograft system. Bone5: 447–454, 1996.
29.
UristMR, MaedaH, ShamieAN, TeplicaD. Endogenous bone morphogenetic protein expression in transplants of urinary bladder: endogenous bone morphogenetic protein expression in transplants of urinary bladder. Plast Reconstr Surg101: 408–415, 1998.
30.
HatakeyamaS, GaoYH, Ohara-NematpY, KataokaH, SatchM. Expression of bone morphogenetic proteins of human neoplastic epithelial cells. Biochem Mol Biol Intl47: 497–505, 1997.
31.
RavalP, HsuMT, AndersonHC. Osteoinductive ability of confluent Saos-2 cells correlates with enhanced expression of bone morphogenetic proteins. J Orthop Res14: 605–610, 1996.
32.
WlodarskiK, OstrowskiK, ChlopkiewiczB, KoziorowskaJ. Correlation between the agglutinability of living cells by Concanavalin A and their ability to induce cartilage and bone formation. Cale Tiss Res16: 251–255, 1974.
33.
CuiY, JeanF, ThomasG, ChristianJL. BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development. EMBO J17: 4735–4743, 1998.
34.
ConstamDB, RobertsonEJ. Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. J Cell Biol144: 139–149, 1999.
35.
IsraelDI, NoveJ, KernsKM, MoutsatsosIK, KaufmanRJ. Expression and characterization of bone morphogenetic protein-2 in Chinese hamster ovary cells. Growth Factors7: 139–150, 1992.
36.
ChenD, FengJQ, FengM, HarrisMA, MundyGR, HarrisSE. Cloning and sequence of bone morphogenetic protein 4 cDNA from fetal rat calvarial cell. Biochim Biophys Acta1174: 289–292, 1993.
37.
GitelmanSE, KobrinMS, YeJQ, LopezAR, LeeA, DerynckR. Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol126: 1595–1609, 1994.
38.
MolloySS, BresnahanPA, LepplaSH, KlimpelKR, ThomasG. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem267: 16396–16402, 1991.
